Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.4.2 to v3.4.3 on the page. This appears to be a minor maintenance update and does not affect the study information presented.
    Difference
    0.0%
    Check dated 2026-03-12T02:33:06.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the government funding lapse notice and Revision: v3.4.1, representing administrative site updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:22:23.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government-funding notice was added about the NIH Clinical Center's status, and the page revision version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:29:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary is now available; Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 are added, while Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:33:07.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:42:04.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Introduced a consolidated Locations section listing states and District of Columbia (California, District of Columbia, Florida, Georgia, Illinois, Maryland, Michigan, Missouri, New York, North Carolina, Ohio, Oregon, Tennessee, Texas, Washington, Wisconsin) and removed the separate per-state location pages.
    Difference
    1%
    Check dated 2025-12-23T17:29:34.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.